Heyu Chen

2 Patents

• US125961222026

  LILRB2 Antibodies and Uses Thereof

  IMMUNE-ONC THERAPEUTICS, Inc.

  0 cites
• US125707102026

  Targeting LILRB4 with CAR-T or CAR-NK Cells in the Treatment of Cancer

  THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM

  0 cites